Article Details

AstraZeneca Boosts Heart, Kidney Business with $1.8 bln CinCor Deal

Retrieved on: 2023-01-09 20:11:59

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Boosts Heart, Kidney Business with $1.8 bln CinCor Deal. View article details on hiswai:

Excerpt

According to Reuters, AstraZeneca said it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc for up to $1.8 billion to increase ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up